Vimarsana
Biggest News Aggregation in the World

Page 6 - Ib Communications News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ib Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ib Communications Today - Breaking & Trending Today

BioSenic provides update regarding current license agreement with Phebra - Vimarsana News

BioSenic provides update regarding current license agreement with Phebra

INSIDE INFORMATION Maintenance of the license isnow subject to the launch of the OATO Phase III before May 2024instead of 31 May 2023 Parties also…

BioSenic provides update regarding current license agreement with Phebra - Vimarsana News

BioSenic provides update regarding current license agreement with Phebra

INSIDE INFORMATION Maintenance of the license is now subject to the launch of the OATO Phase III before May 2024 instead of 31 May 2023 Parties also currently negotiating a potential renegotiation... | May 29, 2023

BioSenic and Pluristyx sign term sheet for market - Vimarsana News

BioSenic and Pluristyx sign term sheet for market

INSIDE INFORMATION Potential license agreement to produce and commercialize original and transformed ALLOB cells BioSenic to potentially receive royalty...

Orgenesis Academy Graduates First Class of Cell and Gene Therapy Experts from theraCell Laboratories-backed Master's Program - Vimarsana News

Orgenesis Academy Graduates First Class of Cell and Gene Therapy Experts from theraCell Laboratories-backed Master's Program

GERMANTOWN, Md., May 22, 2023 -- Orgenesis Inc. , a global biotech company working to unlock the full potential of cell and gene therapies , today announced the first graduating class from a... | May 22, 2023

BioSenic provides First Quarter 2023 Business Update - Vimarsana News

BioSenic provides First Quarter 2023 Business Update

REGULATED INFORMATION ALLOB Phase IIb topline results foreseen in July/August 2023Ongoing discussions for key partnerships with lead clinical assets Mont-Saint-Guibert, Belgium, May 22nd,... | May 22, 2023